Dr. Ranjith Ramasamy touches on myths surrounding testosterone therapy as well as new and forthcoming treatments.
Deep Dive - Season 1
Advertisement
Congressman Brad Wenstrup joins Deep Dive to discuss the efforts of educating the public about the COVID-19 vaccine.
Anita H. Clayton, MD, joins Deep Dive to explore the wide and varied field of maternal mental health.
Dr. Patrick Hwu joins Deep Dive to discuss his leadership at Moffitt Cancer Center.
Dr. Vivian Bucay joins Deep Dive to discuss the evolution of topical growth factors using Aesthetics Biomedical’s SoME skincare.
Dr. Rachael Phelps and Dr. Amber Truehart join Deep Dive to discuss long-acting reversible contraception (LARC) in the time of COVID-19 and telehealth.
Dental researchers continue to look at the ways oral health impacts overall health with numerous links between periodontal disease and conditions affecting the heart and numerous other organs and systems.
Dr. Lori Pierce joins Deep Dive to discuss the Clinical Treatment Act and what physicians need to know about it.
Lori Robbins and Chris Ober join Deep Dive to discuss the financial aspects and tax implications of selling a practice.
On this episode of Deep Dive, Stephen Cital, RVT with a background in cannabis research, provides insight on the hot topic of CBD in the veterinary world. He discusses what fueled his passion for veterinary CBD research, how veterinarians should go about discussing the CBD topic with clients, and beyond. Plus, he previews a textbook he coedited titled, “Cannabis Therapy in Veterinary Medicine.”
Advertisement
Bash Halow joins Deep Dive to discuss the toll that politics, policy and the pandemic are taking on workplace relationships and how to alleviate those strains. This segment explores the various stressors placed on veterinary professional relationships with their teams and clients from external influences like the pandemic, and internal team leadership struggles.
Dr. Daniel Claassen, a Huntington's disease specialist and the head of Vanderbilt’s HD Center of Excellence, joins Deep Dive.
Two new therapies for presbyopia are in the pipeline. Allergan recently submitted an NDA for its investigational eye drop to treat the condition, and Visus Therapeutics recently received FDA acceptance of its investigational new drug application for Brimochol. Dr. Michael Robinson from Allergan and Dr. Rhett Schiffman from Visus join Deep Dive to talk about how the products work and what’s coming next.
Dr. Rachel Phelps and Dr. Amber Truehart join Deep Dive to discuss the impact of COVID-19 on contraceptive care. They also talk about the role of telehealth and in-person visits to help patients with this important part of their healthcare during this difficult time.
Dan Ollendorf joins Deep Dive to discuss drug pricing and cost effectiveness.
Dr. Melissa Stenstrom joins Deep Dive to discuss the importance of skin cancer screenings, as well as encouraging regular sun protection usage among patients. She also talks about the role of telemedicine in skin cancer screenings, her top product recommendations for sun protection and tips on managing patient expectations.
Dr. Leon McDougle joins Deep Dive to discuss how the COVID-19 pandemic has exposed, and could help address, racial disparities in healthcare access and outcomes.
Dr. Mehmet Sitki Copur joins Deep Dive to discuss the background, benefits, and current research regarding messenger RNA (mRNA) vaccines and how they could impact the future of cancer care. The two approved mRNA vaccines for the prevention of COVID-19 present an opportunity to learn more about the potential applications of mRNA vaccines for cancer immunotherapy moving forward.
Dr. Maria Hernandez joins Deep Dive to discuss physician bias.
Bethany Hall, MSN, joins Deep Dive to discuss pediatric Complex Developmental Trauma (CDT), and how understanding CDT can be helpful when caring for pediatric populations.
Dr. Maurie Markman joins Deep Dive to discuss mRNA vaccines, what we can learn from the development of these products, and how these lessons can apply to cancer therapies.
Scott Knoer, the EVP and CEO of the American Pharmacists Association, joins Deep Dive to discuss the Pharmacy and Medically Underserved Area Enhancement Act
Dr. Norman Sharpless, head of the National Cancer Institute, joins Deep Dive to discuss the 50% decline in U.S. cancer diagnoses in 2020 after the COVID-19 pandemic hit the country. He also discusses what the abrupt decline might mean for future diagnoses and how that could affect treatment.
Dr. Julie Gralow joins Deep Dive to discuss her new position as chief medical officer of the American Society for Clinical Oncology (ASCO). Dr. Gralow speaks about her goals and vision for ASCO and provides updates on ASCO’s TAPUR trial in oncology.
Dr. Benjamin Miller joins Deep Dive to discuss how only 1 in 3 primary care practices in the United States have a mental health expert on staff, compared to 90% of in other parts of the world. As more primary care physicians get tapped to distribute COVID-19 vaccines, Dr. Miller talks about how the United States is failing to address the growing mental health epidemic within the pandemic.
Dan Volz and Dr. Dileep Yavagal join Deep Dive to discuss the partnership between Medtronic & MT2020+ and give insight on the collaboration and success of Medtronic’s similar IMMEDIATE program.
Dr. Katherine Phillips joins Deep Dive to discuss body dysmorphic disorder.
Seven-time NASCAR Cup Series champion Jimmie Johnson joins Deep Dive to discuss how ocular allergies affect his driving and day-to-day life.
Dr. Charles Lee joins Deep Dive to discuss the importance of a new law in Oregon that requires pharmacies to print prescription labels in multiple languages. Dr. Lee talks about how patients with limited english proficiency are more likely to make mistakes on medication dosing.
Dr. Brenda Cassidy joins Deep Dive to discuss the important role health care professionals have to play in combating human and child trafficking. She explains specific signs that healthcare professionals should be looking for when they feel their patient may be a human trafficking victim and the importance of spotting these red flags even with COVID-19 limitations.
